Search for: "Finnegan, Henderson, Farabow, Garrett, " Results 181 - 200 of 309
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
19 Apr 2013, 9:27 pm by Patent Docs
Irving of Finnegan Henderson Farabow Garrett & Dunner and Lauren L. [read post]
27 Mar 2021, 8:36 pm by Patent Docs
Andy Culbert of Perkins Coie will moderate a panel consisting of Erik Puknys of Finnegan, Henderson, Farabow, Garrett & Dunner LLP; Roberto Rodrigues of Licks Attorneys; Robert Parker of Rothwell, Figg, Ernst and Manbeck, P.C.; Stephan Wolke of Thyssenkrupp Intellectual Property GmbH; and Bill Harmon of Uber Technologies, Inc. [read post]
9 Jun 2018, 8:57 pm by Patent Docs
MacAlpine of Finnegan Henderson Farabow Garrett & Dunner, and Amelia Feulner Baur and Rebecca B. [read post]
17 Feb 2018, 8:15 pm by Patent Docs
Murphy of Finnegan Henderson Farabow Garrett & Dunner will provide guidance for patent counsel on identifying and determining inventorship, offer best practices for correcting errors regarding inventorship, and offer perspectives gained from working with the AIA since it was passed—and outline lessons from recent court decisions. [read post]
12 May 2018, 9:22 pm by Patent Docs
Rudolph of Finnegan Henderson Farabow Garrett & Dunner will provide guidance to counsel on the impact of the Federal Circuit's decision in Travel Sentry Inc. v. [read post]
8 Dec 2018, 8:05 pm by Patent Docs
Murphy of Finnegan Henderson Farabow Garrett & Dunner will provide guidance to patent counsel on the patentability requirements in the USPTO and EPO for claiming a broad genus of antibodies, recent case law that could impact those claims, and how to best protect antibody inventions in light of the recent developments. [read post]
6 Feb 2016, 7:41 pm by Patent Docs
Murphy of Finnegan Henderson Farabow Garrett & Dunner, and Donna M. [read post]
19 Mar 2023, 9:21 pm by Patent Docs
Burgy of Finnegan Henderson Farabow Garrett & Dunner will guide patent counsel on the issues surrounding Risk Evaluation and Mitigation Strategy (REMS) patents and listing in the Orange Book, discuss REMS patents and what patent prosecutors need to know, address the current efforts of the USPTO and FDA to... [read post]
16 Jul 2010, 9:35 pm by Patent Docs
Arner of Finnegan Henderson Farabow Garrett & Dunner; Leigh J. [read post]
26 May 2013, 8:50 pm by Patent Docs
Michael Jakes of Finnegan, Henderson, Farabow, Garrett & Dunner, LLP will provide their thoughts on the following topics: • Bolstering the specification of a patent to follow the line of reasoning in RCT and Ultramercial; • Including as much detail as possible... [read post]
12 Nov 2016, 9:32 pm by Patent Docs
Murphy, Ph.D. of Finnegan Henderson Farabow Garrett & Dunner, and Wanli Tang, Ph.D. of Jones Day will provide patent counsel with a review of how means-plus-function and/or functional claims are used after the Williamson decision as well as the benefits and risks involved with using means-plus-function and/or functional claims in view of both litigation in the district courts and IPRs... [read post]
9 Feb 2019, 9:48 pm by Patent Docs
Leiman of Finnegan Henderson Farabow Garrett & Dunner will guide patent counsel for overcoming § 101 rejections for biotech patents, review recent case law and USPTO guidance on § 101 patent eligibility, and offer strategies to address § 101 rejections. [read post]
21 Nov 2015, 8:24 pm by Patent Docs
Irving of Finnegan Henderson Farabow Garrett & Dunner; Donna M. [read post]
7 Apr 2018, 8:16 pm by Patent Docs
Mulcahy of Finnegan Henderson Farabow Garrett & Dunner will examine the latest revisions to the USPTO Manual of Patent Examining Procedure (MPEP), including a discussion of patent eligibility, duty to disclose, and other changes to the MPEP, and explore the impact on patent prosecution and provide best practices for applying the new guidance. [read post]
23 Dec 2011, 9:25 pm by Patent Docs
Irving of Finnegan Henderson Farabow Garrett & Dunner will provide guidance on the changes brought by the America Invents Act, a review of the USPTO's post-KSR guidelines and how the courts and USPTO are applying the obviousness standard. [read post]
29 Oct 2016, 8:53 pm by Patent Docs
., and Justin Hasford of Finnegan, Henderson, Farabow, Garrett & Dunner, LLP will discuss the likely impact of the Apple v. [read post]
12 Jan 2019, 8:07 pm by Patent Docs
Feldstein of Finnegan Henderson Farabow Garrett & Dunner and Kurt R. [read post]
17 Nov 2018, 8:12 pm by Patent Docs
Gutowski of Finnegan Henderson Farabow Garrett & Dunner will guide patent counsel on the impact of case law on daily U.S. patent practice, offer best practices of sound principles to prepare and prosecute patent applications to avoid traps for the unwary or careless claim terminology and untoward language in the specification, and also give real-world... [read post]
16 Feb 2014, 8:29 pm by Patent Docs
A panel consisting of Anthony Tridico of Finnegan, Henderson, Farabow, Garrett & Dunner, LLP; Heather Repicky of Nutter McClennen & Fish LLP; and Buckmaster De Wolf, General Counsel of GE Global Research will discuss the case law that governs situations involving patent agents and foreign lawyers, and what internal procedures companies and law firms should rely on to maintain privilege whenever possible. [read post]
16 May 2014, 9:50 pm by Patent Docs
Irving of Finnegan Henderson Farabow Garrett & Dunner; Donna M. [read post]